Sarepta Therapeutics Financial Overview
Sarepta Therapeutics's market cap is currently $2.28B. The company's EPS TTM is $-1.8; its P/E ratio is ―; Sarepta Therapeutics is scheduled to report earnings on November 3, 2025, and the estimated EPS forecast is $-1.34. See an overview of income statement, balance sheet, and cash flow financials.
